Raymond James Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $37.3M | Buy |
328,405
+6,171
| +2% | +$733K | 0.81% | 21 |
|
|
2024
Q2 | $39.9M | Buy |
322,234
+4,265
| +1% | +$549K | 0.94% | 20 |
|
|
2024
Q1 | $42M | Sell |
317,969
-967
| -0.3% | -$119K | 1.02% | 13 |
|
|
2023
Q4 | $34.8M | Buy |
318,936
+12,367
| +4% | +$1.28M | 0.92% | 16 |
|
|
2023
Q3 | $31.6M | Buy |
306,569
+9,610
| +3% | +$1.04M | 0.94% | 16 |
|
|
2023
Q2 | $34.3M | Buy |
296,959
+2,567
| +0.9% | +$291K | 0.99% | 13 |
|
|
2023
Q1 | $31.3M | Buy |
294,392
+230
| +0.1% | +$24.8K | 0.99% | 14 |
|
|
2022
Q4 | $32.6M | Buy |
294,162
+2,611
| +0.9% | +$267K | 1.1% | 12 |
|
|
2022
Q3 | $25.1M | Buy |
291,551
+11,720
| +4% | +$1.05M | 0.94% | 18 |
|
|
2022
Q2 | $25.5M | Sell |
279,831
-10,498
| -4% | -$931K | 0.91% | 20 |
|
|
2022
Q1 | $23.8M | Buy |
290,329
+1,355
| +0.5% | +$107K | 0.73% | 28 |
|
|
2021
Q4 | $22.1M | Sell |
288,974
-5,282
| -2% | -$421K | 0.66% | 36 |
|
|
2021
Q3 | $22.1M | Buy |
294,256
+1,421
| +0.5% | +$108K | 0.74% | 29 |
|
|
2021
Q2 | $22.8M | Sell |
292,835
-20,941
| -7% | -$1.56M | 0.76% | 28 |
|
|
2021
Q1 | $23.1M | Buy |
313,776
+4,354
| +1% | +$321K | 0.8% | 26 |
|
|
2020
Q4 | $24.2M | Buy |
309,422
+1,235
| +0.4% | +$94.5K | 0.92% | 20 |
|
|
2020
Q3 | $24.4M | Buy |
308,187
+10,074
| +3% | +$789K | 1.05% | 17 |
|
|
2020
Q2 | $22M | Buy |
298,113
+8,829
| +3% | +$665K | 1.06% | 17 |
|
|
2020
Q1 | $21.2M | Buy |
289,284
+7,977
| +3% | +$627K | 1.26% | 13 |
|
|
2019
Q4 | $24.4M | Buy |
281,307
+8,988
| +3% | +$738K | 1.16% | 12 |
|
|
2019
Q3 | $21.9M | Buy |
272,319
+1,158
| +0.4% | +$92.8K | 1.13% | 13 |
|
|
2019
Q2 | $21.7M | Buy |
271,161
+4,132
| +2% | +$316K | 1.2% | 13 |
|
|
2019
Q1 | $21.2M | Sell |
267,029
-5,750
| -2% | -$430K | 1.22% | 13 |
|
|
2018
Q4 | $19.9M | Sell |
272,779
-77,743
| -22% | -$5.49M | 1.28% | 11 |
|
|
2018
Q3 | $23.7M | Sell |
350,522
-869
| -0.2% | -$55.4K | 1.34% | 7 |
|
|
2018
Q2 | $20.4M | Buy |
351,391
+22,777
| +7% | +$1.28M | 1.24% | 11 |
|
|
2018
Q1 | $17.1M | Sell |
328,614
-3,339
| -1% | -$180K | 1.18% | 13 |
|
|
2017
Q4 | $17.8M | Sell |
331,953
-1,245
| -0.4% | -$69K | 1.2% | 14 |
|
|
2017
Q3 | $20.4M | Sell |
333,198
-12,695
| -4% | -$770K | 1.46% | 6 |
|
|
2017
Q2 | $21.2M | Sell |
345,893
-85,998
| -20% | -$5.23M | 1.58% | 6 |
|
|
2017
Q1 | $26.2M | Buy |
431,891
+76,670
| +22% | +$4.65M | 1.99% | 4 |
|
|
2016
Q4 | $20M | Sell |
355,221
-1,660
| -0.5% | -$97.1K | 1.59% | 8 |
|
|
2016
Q3 | $21.3M | Buy |
356,881
+2,924
| +0.8% | +$171K | 1.83% | 6 |
|
|
2016
Q2 | $19.5M | Buy |
353,957
+11,387
| +3% | +$606K | 1.71% | 5 |
|
|
2016
Q1 | $17.3M | Buy |
342,570
+78,404
| +30% | +$3.84M | 1.61% | 7 |
|
|
2015
Q4 | $13.3M | Buy |
264,166
+29,666
| +13% | +$1.5M | 1.23% | 12 |
|
|
2015
Q3 | $11.1M | Sell |
234,500
-4,585
| -2% | -$244K | 1.24% | 12 |
|
|
2015
Q2 | $13M | Buy |
239,085
+48,064
| +25% | +$2.7M | 1.38% | 9 |
|
|
2015
Q1 | $10.5M | Buy |
191,021
+18,245
| +11% | +$1.03M | 1.12% | 15 |
|
|
2014
Q4 | $9.36M | Buy |
172,776
+8,657
| +5% | +$482K | 1.01% | 15 |
|
|
2014
Q3 | $9.28M | Buy |
164,119
+1,286
| +0.8% | +$72.2K | 1.06% | 16 |
|
|
2014
Q2 | $8.99M | Sell |
162,833
-665
| -0.4% | -$36.3K | 1.03% | 17 |
|
|
2014
Q1 | $8.86M | Buy |
163,498
+2,493
| +2% | +$129K | 1.09% | 18 |
|
|
2013
Q4 | $7.69M | Sell |
161,005
-16,177
| -9% | -$739K | 1.01% | 21 |
|
|
2013
Q3 | $8.05M | Buy |
177,182
+5,566
| +3% | +$254K | 1.24% | 14 |
|
|
2013
Q2 | $7.61M | Buy |
+171,616
| New | +$7.67M | 1.24% | 17 |
|
Other funds holding MRK
Raymond James Trust's MRK Position: Q3 2024 in Review
Raymond James Trust increased its Merck (MRK) stake by 1.9% in Q3 2024, buying an estimated $733K and bringing the position to 328,405 shares worth $37.3M. The position accounts for 0.81% of the portfolio, ranked #21.
Raymond James Trust first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $42M in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- Raymond James Trust held 328,405 shares of Merck worth $37.3M as of Q3 2024.
- Raymond James Trust bought 6,171 Merck shares in Q3 2024, an estimated $733K.
- Merck made up 0.81% of Raymond James Trust's portfolio in Q3 2024, its #21 holding.
- Raymond James Trust first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
- Raymond James Trust's Merck position peaked at $42M in Q1 2024.
- 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.